TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance

Veenu Tripathi1, Jee-Hye Shin1, Christina H Stuelten1

  • 1Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

Oncogene
|January 11, 2019
PubMed

Insights

Transforming growth factor-β (TGF-β) induces epithelial-to-mesenchymal transition (EMT) and drug resistance. We found a novel mechanism involving RNA-binding proteins that controls TGF-β-activated kinase 1 (TAK1) splicing, impacting cancer cell survival and apoptosis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Transforming growth factor-β (TGF-β) is a key regulator of epithelial-to-mesenchymal transition (EMT), a process linked to cancer metastasis and therapeutic resistance.
  • Previous work identified Smad3 and PCBP1 complex regulating alternative splicing in response to TGF-β, favoring EMT-associated isoforms.
  • The distinct roles of TGF-β-activated kinase 1 (TAK1) isoforms in cellular responses remain incompletely understood.

Purpose of the Study:

  • To elucidate the mechanism controlling the alternative splicing of TAK1 in response to TGF-β.
  • To characterize the distinct functions of TAK1 isoforms generated by alternative splicing.
  • To understand the contribution of TAK1 splicing to TGF-β-mediated cellular outcomes, including EMT and drug resistance.

Main Methods:

  • RNA-binding protein immunoprecipitation (RIP).
  • Analysis of alternative splicing events using molecular biology techniques.
  • Functional assays assessing cell signaling pathways (EMT, NF-κB) and apoptosis.
  • Western blotting to detect protein isoforms.

Main Results:

  • The RNA-binding protein Rbfox2 mediates the exclusion of TGF-β-activated kinase 1 (TAK1) exon 12, independent of the Smad3-PCBP1 complex.
  • The alternatively spliced TAK1 isoform lacking exon 12 (TAK1∆E12) is constitutively active and promotes TGF-β-induced EMT and nuclear factor kappa B (NF-κB) signaling.
  • The full-length TAK1 isoform (TAK1FL) promotes TGF-β-induced apoptosis, while TAK1∆E12 confers resistance to chemotherapy and targeted drugs by supporting EMT and NF-κB survival signaling.

Conclusions:

  • A novel splicing mechanism involving Rbfox2 controls TAK1 isoform expression in response to TGF-β.
  • Distinct TAK1 isoforms mediate opposing cellular responses: TAK1∆E12 promotes survival and EMT, while TAK1FL promotes apoptosis.
  • The alternatively spliced TAK1∆E12 isoform is a potential driver of drug resistance in cancer through its pro-EMT and pro-survival signaling activities.

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K
In Vitro Drug Dissolution: Alternative Methods01:17

In Vitro Drug Dissolution: Alternative Methods

Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
231
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.6K